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patients. The findings of our study are unique; traditional as-
sessments of valve outcomes do not include stress echocar-
diography.17-19 Nevertheless, we have demonstrated that
suboptimal repair can include obstructive annuloplasty
and may be important in active individuals who are able
to generate higher gradients during exercise. Therefore,
serial assessments of mitral valve function following
repair should include surveillance of stenosis in addition
to regurgitation.
Limitations
This is a nonrandomized comparison of patients who
underwent mitral repair with either a ring or a band;
therefore, there may be unknown differences between
groups that may have influenced outcomes. Patients
included in our study comprised a small subset of patients
who underwent mitral valve surgery at our institution
during this time period. Therefore, results should not be
generalized to describe all outcomes following repair of
myxomatous degeneration. Patients in our study were
also healthy with few comorbidities, so extending the
conclusions of this study to sick patients, or to patients
with other causes of MR, is not appropriate. Because
this was a cross-sectional cohort study, detailed stress
echocardiography and clinical assessments were made at
different time points following mitral repair. Conclusions
regarding the temporal progression of mitral stenosis
following repair cannot be made.
CONCLUSIONS
Annuloplasty using a complete ring may be associated
with higher mitral valve gradients at rest and at peak
exercise in certain patients. These patients may also have
worse quality of life. In view of these findings, we
recommend careful consideration of annuloplasty type
and size at the time of mitral repair of organic disease.
References
1. Gammie JS, Sheng S, Griffith BP, Peterson ED, Rankin JS, O’Brien SM, et al.
Trends in mitral valve surgery in the United States: results from the Society of
Thoracic Surgeons Adult Cardiac Surgery Database. Ann Thorac Surg. 2009;
87:1431-7; discussion 1437-9.
2. David TE, Armstrong S, Ivanov J. Chordal replacement with polytetrafluoro-
ethylene sutures for mitral valve repair: a 25-year experience. J Thorac
Cardiovasc Surg. 2013;145:1563-9.
3. Falk V, Seeburger J, Czesla M, Borger MA, Willige J, Kuntze T, et al. How does
the use of polytetrafluoroethylene neochordae for posterior mitral valve prolapse
(loop technique) compare with leaflet resection? A prospective randomized trial.
J Thorac Cardiovasc Surg. 2008;136:1205; discussion 1205-6.
4. Jouan J, Berrebi A, Chauvaud S, Menasche P, Carpentier A, Fabiani JN.
Mitral valve reconstruction in Barlow disease: long-term echographic results
and implications for surgical management. J Thorac Cardiovasc Surg. 2012;
143(4 Suppl):S17-20.
5. Chan V, Ruel M, Chaudry S, Lambert S, Mesana TG. Clinical and
echocardiographic outcomes after repair of mitral valve bileaflet prolapse due
to myxomatous disease. J Thorac Cardiovasc Surg. 2012;143(4 Suppl):S8-11.
6. Ibrahim MF, David TE. Mitral stenosis after mitral valve repair for
non-rheumatic mitral regurgitation. Ann Thorac Surg. 2002;73:34-6.The Journal of Thoracic and Car7. Song S, Cho SH, Yang JH, Park PW. Repair for mitral stenosis due to pannus
formation after Duran ring annuloplasty. Ann Thorac Surg. 2010;90:e93-4.
8. Chung CH, Kim JB, Choo SJ, Kim KS, Song H, Song MG, et al. Long-term
outcomes after mitral ring annuloplasty for degenerative mitral regurgitation:
Duran ring versus Carpentier-Edwards ring. J Heart Valve Dis. 2007;16:
536-44; discussion 544-5.
9. Bothe W, Kvitting JP, Swanson JC, G€oktepe S, Vo KN, Ingels NB, et al. How do
annuloplasty rings affect mitral leaflet dynamic motion? Eur J Cardiothorac
Surg. 2010;38:340-9.
10. BotheW, Kvitting JP, Swanson JC, Hartnett S, Ingels NB Jr,Miller DC. Effects of
different annuloplasty rings on anterior mitral leaflet dimensions. J Thorac
Cardiovasc Surg. 2010;139:1114-22.
11. Douglas PS, Garcia MJ, Haines DE, Lai WW, Manning WJ, Patel AR, et al.
ACCF/ASE/AHA/ASNC/HFSA/HRS/SCAI/SCCM/SCCT/SCMR 2011 appro-
priate use criteria for echocardiography. A report of the American College of
Cardiology Foundation Appropriate Use Criteria Task Force, American Society
of Echocardiography, American Heart Association, American Society of Nuclear
Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for
Cardiovascular Angiography and Interventions, Society of Critical Care
Medicine, Society of Cardiovascular Computed Tomography, and Society for
Cardiovascular Magnetic Resonance Endorsed by the American College of Chest
Physicians. J Am Coll Cardiol. 2011;57:1126-66.
12. Mesana T, Ibrahim M, Hynes M. A technique for annular plication to facilitate
sliding plasty after extensive mitral valve posterior leaflet resection. Ann Thorac
Surg. 2005;79:655-65.
13. Mesana T, Ibrahim M, Kulik A, Ruel M, Dover K, Nicholson D, et al. The
‘‘hybrid flip-over’’ technique for anterior leaflet prolapse repair. Ann Thorac
Surg. 2007;83:322-3.
14. Verma S, Mesana TG. Mitral-valve repair for mitral-valve prolapse. N Engl
J Med. 2009;361:2261-9.
15. Spiegelstein D, Moshkovitz Y, Sternik L, Fienberg MS, Kogan A, Malachy A,
et al. Midterm results of mitral valve repair: closed versus open annuloplasty
ring. Ann Thorac Surg. 2010;90:489-95.
16. DiBardino DJ, ElBardissi AW, McClure RS, Razo-Vasquez OA, Kelly NE,
Cohn LH. Four decades of experience with mitral valve repair: analysis of
differential indications, technical evolution, and long-term outcome. J Thorac
Cardiovasc Surg. 2010;139:76-83; discussion 83-4.
17. Seeburger J, Borger MA, Doll N, Walther T, Passage J, Falk V, et al. Comparison
of outcomes of minimally invasive mitral valve surgery for posterior, anterior and
bileaflet prolapse. Eur J Cardiothorac Surg. 2009;36:532-8.
18. Castillo JG, Anyanwu AC, Fuster V, Adams DH. A near 100% repair rate for
mitral valve prolapse is achievable in a reference center: implications for future
guidelines. J Thorac Cardiovasc Surg. 2012;144:308-12.
19. Jimenez JH, Forbess J, Croft LR, Small L, He Z, Yoganathan AP. Effects of
annular size, transmitral pressure, andmitral flow rate on the edge-to-edge repair:
an in vitro study. Ann Thorac Surg. 2006;82:1362-8.
20. Seeburger J, Falk V, Borger MA, Passage J, Walther T, Doll N, et al.
Chordae replacement versus resection for repair of isolated posterior mitral
leaflet prolapse: a egalite. Ann Thorac Surg. 2009;87:1715-20.
21. Royce C, Donnan G, Royse A. Assessing the basic hemodynamic state. In:
Royce C, Donnan G, Royse A, eds. Pocket guide of perioperative and
critical care echocardiography. New York: McGraw-Hill Medical; 2006:30-45.
22. Doust JA, Pietrzak E, Dobson A, Glasziou P. How well does B-type natriuretic
peptide predict death and cardiac events in patients with heart failure: systematic
review. BMJ. 2005;330:625.
23. Lam BK, Chan V, Hendry P, Ruel M, Masters R, Bedard P, et al. The impact
of patient-prosthesis mismatch on late outcomes after mitral valve replacement.
J Thorac Cardiovasc Surg. 2007;133:1464-73.
24. Bothe W, Kuhl E, Kvitting JP, Rausch MK, G€oktepe S, Swanson JC, et al. Rigid,
complete annuloplasty rings increase anterior mitral leaflet strains in the normal
beating ovine heart. Circulation. 2011;124(11 Suppl):S81-96.Discussion
Dr David H. Adams (New York, NY). I envy very much your
dedicated mitral valve disease clinic and outcomes center, which
I saw firsthand during a recent visit. I also applaud your dedication
to follow-up of patients after mitral valve repair and absolutely
agree that we have a responsibility to get echocardiographic anddiovascular Surgery c Volume 146, Number 6 1423
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Dclinical follow-up on patients following operation, particularly
because guidelines recommend early intervention in asymptom-
atic patients.
Having said that, I think this particular effort to convince us to
stop using complete rings to potentially limit the degree of
functional mitral stenosis following repair falls well short of the
mark. Other than ring type, there are several key differences in
your 2 groups that are worthy of comment. First, in your previous
publication last year on patients with bileaflet prolapse and
echocardiographic outcome, many of whom I’m sure reappeared
for this analysis, you stated that you have been using future bands
exclusively since 2004. We all know we are resecting less tissue
and focusing more on techniques that preserve leaflet mobility in
recent years. Any potential change in functional results are just
as likely to be due to better leaflet strategies as opposed to
annuloplasty choice. For example, your use of edge-to-edge
sutures is higher in the ring group, and these were used in the
earlier era, and my guess is that explains some of your outcomes
on an exercise bike.
Furthermore, we need to know the interval between the surgical
date and the study echo in each group, as you point out. All of the
rings were used very early in your series—before 2004. Leaflet
thickening and pannus formation are temporal events and may
again explain some of your findings.
Third, by my calculation, 42% of your ring patients returned to
participate in this study whereas only 13% of the band patients
signed up. Either there was a significant recruitment bias or other
factors are in play. This is another issue that needs comment.
The other key difference worth highlighting when considering
your Short Form-36 data is that 46% of patients in your band group
were operated on and were asymptomatic at the time of surgery
compared with only 21% in the ring group. I’m pretty sure that
it is easier to make an asymptomatic patient feel good after surgery
versus a symptomatic one.
Here are a few final questions. We tend to see what we want to
see on echos. In your article last year on bileaflet prolapse, you
described excellent echo outcomes with only 1 case that developed
stenosis in 142 patients. In this study, was your echo team blinded
to the reason for the follow-up study echo and blinded to the ring
type in this analysis? How do you reconcile the differences in your
findings in this study and your former?
You note in your article that you choose rings based on the in-
tertrigonal distance measured with sizers. That is another potential
issue, because the notches on the future band sizers correlate to
trigones according to the manufacturer, whereas on the Physio
ring (Carpentier-Edwards Physio Annuloplasty Ring [Baxter
Healthcare Corp, Irvine, Calif]) they correlate to the commissures.
If you chose sizes as stated in your article, you would have
necessarily downsized the Physio rings. Please clarify that for us.
Finally, in your article you state there were no patients
that developed >1+ mitral regurgitation during any time of
follow-up. That is very unusual. We know from our series and
those of Dr David and others, that 0.5% per year to 1% per year
develop recurrent, significant mitral regurgitation. Can you clarify
that for us?
I respect your group a lot, but you are comparing apples and
oranges, and this question of ring versus band and functional
outcomes needs further study.1424 The Journal of Thoracic and Cardiovascular SurDr ThierryMesana (Ottawa, Ontario, Canada). Thank you for
those well-made points. I would like to answer the last question
very quickly. I never said I had no patients with >1+ mitral
regurgitation. I said that in this study when we recruited patients
wewere careful therewas no patient with>1+mitral regurgitation.
So in this study there are no patients with mitral regurgitation who
could compromise the analysis of the data.
It is true that there is a lot of bias in this study, because most of
these rings were used at the very early stage of the last decade of
practice at the Heart Institute, and then we moved roughly after
2004 into the use of bands, because basically we have seen some
patients with symptomatic mitral stenosis after implantation of a
ring. I was approached by cardiologists whowanted to do this study
because they wanted to understand what was going on. And in this
study, the common point between the 2 groups is that there is no
difference in techniques other than the use of band versus ring.
Indeed, we have evolved in the past 3 or 4 years—doing less sliding
plasty and less aggressive resection of the valve. There is no doubt
of this. But in this study, most patients had more than 5 years’
follow-up, and they are more likely to be recipients of the oldest
way of practicing mitral valve repair; that is, with less Gore-Tex
(W. L. Gore & Associates, Inc, Flagstaff, Ariz) and more sliding
and more leaflet resection. Nevertheless, these patients are similar,
and we have identified the problem of the ring.
I believe sincerely that annuloplasty is not a benign device, and
we should be more careful when we put these full rings in patients
who have not a very large annulus. The problem has been
identified because we follow our patients very carefully, as you
mentioned initially in your comments, every year, at the Heart
Institute.
It is not in contradiction with the previous article I published,
which was only on bileaflet prolapse and included even more
future bands than in this study where we have a cohort that is
different. Did I answer the questions?
Dr Adams. That is a good start. I think it’s a really interesting
topic, Thierry, and I think you are really challenging us to think
about it. I’m still skeptical, but you got my attention.
Dr Marek A. Deja (Katowice, Poland). It is very interesting
data that you are showing. What was the total energy expenditure
on exercise in both groups and was there a correlation of the
gradient that you produced with the level of exercise the patient
was performing? Maybe some of the patients were performing a
bigger exercise. I wish I had seen the spiroergometry on these
patients and seen if their exercise capacity was different.
Dr Mesana. Well, we have to understand something here.
These patients are not doing badly. They are just not as good as
they should be, particularly the younger patients. So we push
them very hard during stress exercise. I was there a few times.
They are pushed to exertion. And when you are asking
cardiologists to send you patients for asymptomatic mitral
regurgitation, the patient should be able to do at least as much as
they were doing before. We have done a substudy of that, which
is not presented here. We believe as surgeons that a mean mitral
valve gradient<5 is fine.
Actually we did a control study at the same time as we looked at
these patients. We studied 21 patients with normal native valve and
normal heart function, and the cutoff line for having no gradient at
exercise is a mean gradient at rest of 3, and when we come back togery c December 2013
Mesana et al Acquired Cardiovascular Diseasethe data and we look at all the patients who had a gradient>3, then
all the data on symptoms became significant. So all the data that
are borderline and significant become very significant. The
cardiologists came to me and said, ‘‘Surgeons believe that mean
gradient of 5 is right. We believe that 3 is right.’’ So this is a debate
for the future.
Dr Y. Joseph Woo (Philadelphia, Pa). Just a follow-up on the
residual regurgitation issue. Do you know how many patients in
the band group had at least 2+ residual regurgitation at long-
term follow-up, and were thus excluded from your analysis by
intent? You may have traded 1 problem for another.The Journal of Thoracic and CarDrMesana.We excluded any patient in this study that had any-
thing>1+.
Dr Woo. How many patients were excluded who had
regurgitation?
Dr Mesana. I think there were approximately 3% of the
patients overall. Interestingly, during exercise, although 3
patients with symptomatic mitral stenosis had 2+ mitral
regurgitation during exercise, and some of these patients then
became very symptomatic. But as soon as they stopped resting,
they had no more mitral regurgitation. We could monitor this
during exercise.diovascular Surgery c Volume 146, Number 6 1425
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